LivaNova (NASDAQ:LIVN) Sets New 12-Month High – Should You Buy?

Shares of LivaNova PLC (NASDAQ:LIVN) reached a new 52-week high on Friday . The stock traded as high as $65.95 and last traded at $64.6850, with a volume of 38349 shares traded. The stock had previously closed at $64.71.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on LIVN shares. Stifel Nicolaus boosted their target price on shares of LivaNova from $65.00 to $70.00 and gave the company a “buy” rating in a research report on Wednesday, January 7th. Mizuho boosted their price objective on shares of LivaNova from $70.00 to $72.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. Barclays raised their target price on shares of LivaNova from $58.00 to $67.00 and gave the stock an “equal weight” rating in a report on Friday, January 9th. Robert W. Baird set a $75.00 price target on LivaNova in a research note on Tuesday, December 16th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of LivaNova in a research report on Monday, December 29th. Six equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, LivaNova presently has an average rating of “Moderate Buy” and a consensus price target of $69.38.

LivaNova Price Performance

The firm has a market capitalization of $3.53 billion, a P/E ratio of -16.15 and a beta of 0.97. The company has a quick ratio of 1.12, a current ratio of 1.33 and a debt-to-equity ratio of 0.30. The business’s 50 day moving average is $62.88 and its 200-day moving average is $55.69.

Hedge Funds Weigh In On LivaNova

Institutional investors have recently modified their holdings of the business. Artisan Partners Limited Partnership grew its holdings in shares of LivaNova by 94.5% during the 3rd quarter. Artisan Partners Limited Partnership now owns 2,427,045 shares of the company’s stock valued at $127,129,000 after purchasing an additional 1,179,436 shares during the last quarter. Wellington Management Group LLP lifted its stake in LivaNova by 83.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,345,516 shares of the company’s stock valued at $122,858,000 after purchasing an additional 1,067,349 shares during the last quarter. Invesco Ltd. boosted its position in LivaNova by 714.7% in the second quarter. Invesco Ltd. now owns 1,028,713 shares of the company’s stock valued at $46,313,000 after buying an additional 902,447 shares in the last quarter. Scopia Capital Management LP bought a new stake in shares of LivaNova during the second quarter worth $36,657,000. Finally, Millennium Management LLC increased its holdings in shares of LivaNova by 22.4% during the third quarter. Millennium Management LLC now owns 2,969,814 shares of the company’s stock worth $155,559,000 after buying an additional 544,033 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.